butabarbital decreases results of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Carefully. Coadministration of CYP3A4 inducers may possibly lessen sufentanil concentrations and efficacy, possibly precipitating withdrawal syndrome in patients who've produced Actual physical dependence to sufent